193 related articles for article (PubMed ID: 34666043)
21. Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C.
Wang T; Zhang W; Tian C; Liu B; Yu Y; Ding L; Spearman P; Yu XF
Virology; 2008 Jul; 377(1):71-9. PubMed ID: 18495196
[TBL] [Abstract][Full Text] [Related]
22. APOBEC3C, a nucleolar protein induced by genotoxins, is excluded from DNA damage sites.
Constantin D; Dubuis G; Conde-Rubio MDC; Widmann C
FEBS J; 2022 Feb; 289(3):808-831. PubMed ID: 34528388
[TBL] [Abstract][Full Text] [Related]
23. Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteins.
Zhang W; Chen G; Niewiadomska AM; Xu R; Yu XF
PLoS One; 2008; 3(12):e3963. PubMed ID: 19088851
[TBL] [Abstract][Full Text] [Related]
24. HIV-1 Vif interaction with APOBEC3 deaminases and its characterization by a new sensitive assay.
Cadima-Couto I; Saraiva N; Santos AC; Goncalves J
J Neuroimmune Pharmacol; 2011 Jun; 6(2):296-307. PubMed ID: 21279453
[TBL] [Abstract][Full Text] [Related]
25. Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.
Sawyer SL; Emerman M; Malik HS
PLoS Biol; 2004 Sep; 2(9):E275. PubMed ID: 15269786
[TBL] [Abstract][Full Text] [Related]
26. A chimeric human APOBEC3A protein with a three amino acid insertion confers differential HIV-1 and adeno-associated virus restriction.
Wang Y; Wang Z; Pramanik A; Santiago ML; Qiu J; Stephens EB
Virology; 2016 Nov; 498():149-163. PubMed ID: 27584592
[TBL] [Abstract][Full Text] [Related]
27. Functional analysis and structural modeling of human APOBEC3G reveal the role of evolutionarily conserved elements in the inhibition of human immunodeficiency virus type 1 infection and Alu transposition.
Bulliard Y; Turelli P; Röhrig UF; Zoete V; Mangeat B; Michielin O; Trono D
J Virol; 2009 Dec; 83(23):12611-21. PubMed ID: 19776130
[TBL] [Abstract][Full Text] [Related]
28. A Single Nucleotide Polymorphism in Human APOBEC3C Enhances Restriction of Lentiviruses.
Wittkopp CJ; Adolph MB; Wu LI; Chelico L; Emerman M
PLoS Pathog; 2016 Oct; 12(10):e1005865. PubMed ID: 27732658
[TBL] [Abstract][Full Text] [Related]
29. Determinants of FIV and HIV Vif sensitivity of feline APOBEC3 restriction factors.
Zhang Z; Gu Q; Jaguva Vasudevan AA; Hain A; Kloke BP; Hasheminasab S; Mulnaes D; Sato K; Cichutek K; Häussinger D; Bravo IG; Smits SH; Gohlke H; Münk C
Retrovirology; 2016 Jul; 13(1):46. PubMed ID: 27368163
[TBL] [Abstract][Full Text] [Related]
30. APOBEC3 Host Restriction Factors of HIV-1 Can Change the Template Switching Frequency of Reverse Transcriptase.
Adolph MB; Ara A; Chelico L
J Mol Biol; 2019 Mar; 431(7):1339-1352. PubMed ID: 30797859
[TBL] [Abstract][Full Text] [Related]
31. APOBEC3B and APOBEC3C are potent inhibitors of simian immunodeficiency virus replication.
Yu Q; Chen D; König R; Mariani R; Unutmaz D; Landau NR
J Biol Chem; 2004 Dec; 279(51):53379-86. PubMed ID: 15466872
[TBL] [Abstract][Full Text] [Related]
32. Functional and Structural Insights into a Vif/PPP2R5 Complex Elucidated Using Patient HIV-1 Isolates and Computational Modeling.
Salamango DJ; McCann JL; Demir Ö; Becker JT; Wang J; Lingappa JR; Temiz NA; Brown WL; Amaro RE; Harris RS
J Virol; 2020 Oct; 94(21):. PubMed ID: 32847850
[TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C.
Baumert TF; Rösler C; Malim MH; von Weizsäcker F
Hepatology; 2007 Sep; 46(3):682-9. PubMed ID: 17625792
[TBL] [Abstract][Full Text] [Related]
34. Analysis of the N-terminal positively charged residues of the simian immunodeficiency virus Vif reveals a critical amino acid required for the antagonism of rhesus APOBEC3D, G, and H.
Schmitt K; Katuwal M; Wang Y; Li C; Stephens EB
Virology; 2014 Jan; 449():140-9. PubMed ID: 24418547
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 and HIV-2 Vif interact with human APOBEC3 proteins using completely different determinants.
Smith JL; Izumi T; Borbet TC; Hagedorn AN; Pathak VK
J Virol; 2014 Sep; 88(17):9893-908. PubMed ID: 24942576
[TBL] [Abstract][Full Text] [Related]
36. APOBEC3G restricts HIV-1 to a greater extent than APOBEC3F and APOBEC3DE in human primary CD4+ T cells and macrophages.
Chaipan C; Smith JL; Hu WS; Pathak VK
J Virol; 2013 Jan; 87(1):444-53. PubMed ID: 23097438
[TBL] [Abstract][Full Text] [Related]
37. Structural basis of chimpanzee APOBEC3H dimerization stabilized by double-stranded RNA.
Matsuoka T; Nagae T; Ode H; Awazu H; Kurosawa T; Hamano A; Matsuoka K; Hachiya A; Imahashi M; Yokomaku Y; Watanabe N; Iwatani Y
Nucleic Acids Res; 2018 Nov; 46(19):10368-10379. PubMed ID: 30060196
[TBL] [Abstract][Full Text] [Related]
38. Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.
Schröfelbauer B; Senger T; Manning G; Landau NR
J Virol; 2006 Jun; 80(12):5984-91. PubMed ID: 16731937
[TBL] [Abstract][Full Text] [Related]
39. Species-specific inhibition of APOBEC3C by the prototype foamy virus protein bet.
Perkovic M; Schmidt S; Marino D; Russell RA; Stauch B; Hofmann H; Kopietz F; Kloke BP; Zielonka J; Ströver H; Hermle J; Lindemann D; Pathak VK; Schneider G; Löchelt M; Cichutek K; Münk C
J Biol Chem; 2009 Feb; 284(9):5819-26. PubMed ID: 19074429
[TBL] [Abstract][Full Text] [Related]
40. Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.
Dang Y; Wang X; York IA; Zheng YH
J Virol; 2010 Sep; 84(17):8561-70. PubMed ID: 20592083
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
